Influence of genotype, viral load and fibrosis on the sustained virologic response rate to pegylated interferon alpha-2a plus ribavirin, with or without amantadine, in chronic hepatitis C patients non-responders to alpha interferferon plus ribavirin

被引：0
|
作者：
Cheinquer, H.
Pessoa, M.
Sette, H., Jr.
Parise, E.
Parana, R.
Tatsch, F.
机构：
[1] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[2] Hosp Emilio Ribas, Sao Paulo, Brazil
[3] Pro Figado, Gastroenterol & Hepatol, Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Sao Paulo, Brazil
[5] Univ Fed Bahia, Salvador, BA, Brazil
[6] Roche, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL VIROLOGY | 2006年 / 36卷
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [41] Interferon and ribavirin with or without amantadine for interferon non-responders with chronic hepatitis C - A randomised, controlled pilot study
    Wenger, Christa
    Bischof, Thomas
    Gonvers, Jean-Jacques
    Renner, Eberhard L.
    Mullhaupt, Beat
    SWISS MEDICAL WEEKLY, 2007, 137 (29-30) : 418 - 423
  • [42] Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
    Lawitz, Eric
    Sulkowski, Mark S.
    Ghalib, Reem
    Rodriguez-Torres, Maribel
    Younossi, Zobair M.
    Corregidor, Ana
    DeJesus, Edwin
    Pearlman, Brian
    Rabinovitz, Mordechai
    Gitlin, Norman
    Lim, Joseph K.
    Pockros, Paul J.
    Scott, John D.
    Fevery, Bart
    Lambrecht, Tom
    Ouwerkerk-Mahadevan, Sivi
    Callewaert, Katleen
    Symonds, William T.
    Picchio, Gaston
    Lindsay, Karen L.
    Beumont, Maria
    Jacobson, Ira M.
    LANCET, 2014, 384 (9956): : 1756 - 1765
  • [43] Autoimmune Hepatitis Triggered by Treatment With Pegylated Interferon alpha-2a and Ribavirin for Chronic Hepatitis C
    Rathi, Chetan
    Pipaliya, Nirav
    Choksi, Dhaval
    Parikh, Pathik
    Ingle, Meghraj
    Sawant, Prabha
    ACG CASE REPORTS JOURNAL, 2015, 2 (04): : 247 - 249
  • [44] The response to interferon plus ribavirin re-treatment for chronic hepatitis C in interferon non-responders is not influenced by race
    De Maria, N
    Colantoni, A
    Idilman, R
    Harig, J
    Van Thiel, DH
    JOURNAL OF HEPATOLOGY, 2000, 33 (06) : 1028 - 1029
  • [45] Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C
    Nomura, H.
    Miyagi, Y.
    Tanimoto, H.
    Ishibashi, H.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (05) : 346 - 351
  • [46] Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues - Reply
    Kamal, Sanaa
    Schardell, Michelle
    El Kamary, Samer
    Hashem, Mohamed
    Mansour, Hoda
    Ibrahim, Amany Sayed
    HEPATOLOGY, 2008, 47 (05) : 1793 - 1794
  • [47] Comparison of the Efficacy of Standard Interferon Alpha 2a Plus Ribavirin and Pegylated Interferon Alpha 2a Plus Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C Infection
    Sumer, Sua
    Ural, Onur
    Demir, Nazlim Aktug
    Ural, Gaye
    Balci, Mehmet
    Dikici, Nebahat
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2009, 14 (03): : 87 - 90
  • [48] Pegylated interferon alpha2b plus ribavirin in non responder and naive chronic hepatitis C patients.
    Ripault, MP
    Martinot, M
    Boyer, N
    Giuily, N
    Castelnau, C
    Pouteau, M
    Tarik, A
    Marcellin, P
    HEPATOLOGY, 2002, 36 (04) : 596A - 596A
  • [49] A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
    You, Byung Chul
    Kim, Young Seok
    Kim, Hun il
    Kim, Se Hun
    Park, Seung Sik
    Seo, Yu Ri
    Kim, Sang Gyune
    Lee, Se Whan
    Kim, Hong Soo
    Jeong, Soung Won
    Jang, Jae Young
    Kim, Boo Sung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2012, 18 (03) : 272 - 278
  • [50] Muscle adiposity influences viral response to pegylated interferon plus ribavirin treatment in patients with genotype 1 chronic hepatitis C
    Okada, Michiaki
    Mizuta, Toshihiko
    Kitajima, Yoichiro
    Kawaguchi, Yasunori
    Iwane, Shinji
    Ide, Yasushi
    Eguchi, Yuichiro
    Anzai, Keizo
    Ozaki, Iwata
    HEPATOLOGY, 2013, 58 : 1152A - 1152A
12345